Cardiff and Vale University Health Board

Specialist MDT: Cardiff and Vale University Health Board

View Provider Services

The following services are available at this Health Board (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Isotope bone scan
    • One-stop diagnostic clinic
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • Joint specialist MDT clinic
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling
    • Genetic counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 396 668
Performance Status recorded 100% 100%
PSA completed 96% 93%
Gleason Score completed 96% 93%
TNM completed 91% 78%
Risk group assigned 99% 99%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 660 34801
Percentage of men diagnosed with metastatic disease 12% 13%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 108 N/A
Percentage of men with low-risk localised disease receiving radical treatment 10% 0%
No. of men diagnosed with locally advanced disease 165 N/A
Percentage of men diagnosed with locally advanced disease receiving radical treatment 74% 0%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2019-2020) 150
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 12%
No. of men who received radical prostatectomy (2018) 110
Adjusted percentage of men experiencing at least one GU complication (%) 7%

Compare provider outcomes